Health information to help you understand symptoms. It isn't a diagnosis.
Check symptoms

Research deep dives

When anal cancer was first understood

Last reviewed November 16, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.

Anal cancer was for most of medical history a rare cancer treated by removing the anus, with no known cause.

Within fifty years it became a largely preventable, usually curable, virus-driven disease treated without surgery. Three moments did most of that work.

Related pages: Anal cancer

The bottom line

What we know
  • Chemoradiation replaced radical surgery after Nigro's 1974 report.
  • Harald zur Hausen established that HPV causes cervical cancer, work recognized with a Nobel Prize in 2008.
  • HPV DNA was identified in anal cancers in the 1980s.
  • The ANCHOR trial showed in 2022 that treating anal precancer prevents cancer.
What is still open
  • How much the rise of HPV vaccination will reduce anal cancer, which will take decades to show.
  • Whether screening will be extended beyond the groups currently covered.

The story, step by step

  1. 1. Before 1974 ()
  2. 2. 1974 ()
  3. 3. 1976 to 1983 ()
  4. 4. The 1980s ()
  5. 5. 2006 to 2022 ()
What the evidence labels mean
GuidelineAn official recommendation from an expert group after weighing all the evidence.
Review of many studiesCombines the results of many studies (a systematic review or meta-analysis).
Randomized trialPeople were randomly given a treatment or a comparison, the best way to test cause and effect.
Large observational studyFollows many people over time. Shows strong links, but not always cause and effect.
Small or early studyA small study, case series, or first results. Needs to be confirmed.
Lab or animal studyDone in cells or animals. May not apply to people.
Part 1 of 5

Surgery, and little understanding

Review of many studies

What happens

Anal cancer was recognized as distinct from rectal cancer but not much more than that.

What the research shows

  • Treatment was abdominoperineal resection, removing the anus and rectum with a permanent colostomy.
  • No cause was known. It was assumed to be related to chronic irritation, as many cancers were.
  • It was uncommon, which meant little research attention.
  • Radiation alone had been tried and was considered inferior to surgery.

Why it matters

A rare cancer with no known cause and one brutal treatment is a disease that stays still for a long time.

What's still uncertain

  • Historical records of anal cancer are complicated by frequent misclassification as rectal cancer.

Read more

Next: 1974

Part 2 of 5

Nigro's accidental discovery

Review of many studies

What happens

Norman Nigro, a surgeon in Detroit, gave chemotherapy and radiation before surgery to shrink tumours, and found the tumours gone.

What the research shows

  • The regimen combined radiation with 5-fluorouracil and mitomycin C.
  • In the first patients, the surgical specimens removed afterwards contained no residual cancer.
  • He published the observation in 1974, and it was not immediately accepted.
  • Larger series and later randomized trials confirmed it, and chemoradiation became definitive treatment rather than preparation for surgery.
  • Anal cancer became an early and influential example of organ preservation in oncology.

Why it matters

A treatment designed as preparation turned out to be the treatment. That reversal defines how anal cancer is managed to this day.

What's still uncertain

  • The original radiation doses were much lower than modern ones and the regimen was refined substantially afterwards.

Read more

Next: 1976 to 1983

Part 3 of 5

zur Hausen, and a very unpopular hypothesis

Review of many studies

What happens

At the same time, the cause was being worked out elsewhere, against considerable resistance.

What the research shows

  • The prevailing view in the 1970s was that herpes simplex virus caused cervical cancer.
  • Harald zur Hausen proposed instead that human papillomavirus was responsible, and spent years looking for it.
  • His group isolated HPV-16 and HPV-18 from cervical cancers in 1983 and 1984.
  • The finding was slow to be accepted and eventually became the basis for the vaccines.
  • He shared the Nobel Prize in Physiology or Medicine in 2008.

Why it matters

The work that made the HPV vaccine possible was, for a decade, a minority position argued against the field's consensus.

What's still uncertain

  • The herpes hypothesis had supporting correlational evidence, which is part of why it persisted.

Read more

Next: The 1980s

Part 4 of 5

The same virus, in the anus

Review of many studies

What happens

The link from cervical to anal cancer followed quickly once the tools existed.

What the research shows

  • HPV DNA, predominantly type 16, was identified in anal squamous cell carcinomas during the 1980s.
  • The parallel with cervical cancer was recognized: same virus, same kind of transformation zone, same progression through dysplasia.
  • The HIV epidemic made the connection unavoidable, as anal cancer rates rose sharply in people with severe immunosuppression.
  • Anal cytology was adapted from cervical cytology, and high-resolution anoscopy was developed from colposcopy.
  • Anal cancer went from an orphan disease to a model of virus-driven carcinogenesis within about a decade.

Why it matters

Almost every tool used in anal cancer screening today was borrowed directly from cervical screening.

What's still uncertain

  • Anal cytology has proved less accurate than its cervical counterpart.

Read more

Next: 2006 to 2022

Part 5 of 5

Vaccine, then proof that treating precancer works

Review of many studies

What happens

The last two decades turned understanding into prevention.

What the research shows

  • The first HPV vaccine was approved in 2006, and the 9-valent version, covering more types, in 2014.
  • Vaccination was extended beyond girls to boys, which matters directly for anal cancer.
  • Whether treating anal high-grade precancer actually prevented cancer remained unproven, so practice varied widely.
  • The ANCHOR trial, in people living with HIV, was stopped early in 2021 when treating precancer was found to reduce progression to cancer by around 57 percent.
  • The 2022 publication established screening and treatment of anal HSIL in high-risk groups as evidence-based rather than plausible.

Why it matters

Fifty years from an accidental observation in an operating theatre to a trial that proved precancer treatment works. That is roughly the pace of real progress in medicine.

What's still uncertain

  • The full effect of vaccination on anal cancer rates will not be visible for decades, since the cancer appears late in life.

Read more

More plain-language reading

See something wrong or unclear on this page? Suggest a correction. OwieClear is for education only and isn't medical advice.